Abiraterone and increased survival in metastatic prostate cancer JS De Bono, CJ Logothetis, A Molina, K Fizazi, S North, L Chu, KN Chi, ... New England Journal of Medicine 364 (21), 1995-2005, 2011 | 5219 | 2011 |
β-Arrestin acts as a clathrin adaptor in endocytosis of the β2-adrenergic receptor OB Goodman Jr, JG Krupnick, F Santini, VV Gurevich, RB Penn, ... nature 383 (6599), 447-450, 1996 | 1812 | 1996 |
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo … K Fizazi, HI Scher, A Molina, CJ Logothetis, KN Chi, RJ Jones, ... The lancet oncology 13 (10), 983-992, 2012 | 1767 | 2012 |
Arrestin/clathrin interaction: Localization of the clathrin binding domain of nonvisual arrestins to the carboxyl terminus JG Krupnick, OB Goodman, JH Keen, JL Benovic Journal of Biological Chemistry 272 (23), 15011-15016, 1997 | 355 | 1997 |
Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant … CJ Logothetis, E Basch, A Molina, K Fizazi, SA North, KN Chi, RJ Jones, ... The lancet oncology 13 (12), 1210-1217, 2012 | 331 | 2012 |
Arrestin/clathrin interaction: localization of the arrestin binding locus to the clathrin terminal domain OB Goodman, JG Krupnick, VV Gurevich, JL Benovic, JH Keen Journal of Biological Chemistry 272 (23), 15017-15022, 1997 | 298 | 1997 |
Niraparib and abiraterone acetate for metastatic castration-resistant prostate cancer KN Chi, D Rathkopf, MR Smith, E Efstathiou, G Attard, D Olmos, JY Lee, ... Journal of Clinical Oncology 41 (18), 3339-3351, 2023 | 221 | 2023 |
Comparison of circulating MicroRNA 141 to circulating tumor cells, lactate dehydrogenase, and prostate-specific antigen for determining treatment response in patients with … JC Gonzales, LM Fink, OB Goodman Jr, JT Symanowski, NJ Vogelzang, ... Clinical genitourinary cancer 9 (1), 39-45, 2011 | 168 | 2011 |
Circulating tumor cells in patients with castration-resistant prostate cancer baseline values and correlation with prognostic factors OB Goodman Jr, LM Fink, JT Symanowski, B Wong, B Grobaski, ... Cancer Epidemiology Biomarkers & Prevention 18 (6), 1904-1913, 2009 | 136 | 2009 |
Circulating tumor cells as a predictive biomarker in patients with hormone-sensitive prostate cancer OB Goodman Jr, JT Symanowski, A Loudyi, LM Fink, DC Ward, ... Clinical genitourinary cancer 9 (1), 31-38, 2011 | 127 | 2011 |
A phase 1 study of a vaccine targeting preferentially expressed antigen in melanoma and prostate-specific membrane antigen in patients with advanced solid tumors JS Weber, NJ Vogelzang, MS Ernstoff, OB Goodman, LD Cranmer, ... Journal of immunotherapy 34 (7), 556-567, 2011 | 116 | 2011 |
Mapping of the molecular determinants involved in the interaction between eps15 and AP-2 G Iannolo, AE Salcini, I Gaidarov, OB Goodman Jr, J Baulida, G Carpenter, ... Cancer research 57 (2), 240-245, 1997 | 113 | 1997 |
Exploratory analysis of the visceral disease subgroup in a phase III study of abiraterone acetate in metastatic castration-resistant prostate cancer OB Goodman, TW Flaig, A Molina, PFA Mulders, K Fizazi, H Suttmann, ... Prostate cancer and prostatic diseases 17 (1), 34-39, 2014 | 112 | 2014 |
Synergistic loss of prostate cancer cell viability by coinhibition of HDAC and PARP OS Chao, OB Goodman Jr Molecular cancer research 12 (12), 1755-1766, 2014 | 103 | 2014 |
Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells J Gong, J Zhu, OB Goodman, RG Pestell, PN Schlegel, DM Nanus, ... Oncogene 25 (14), 2011-2021, 2006 | 90 | 2006 |
Detection of lipid-rich prostate circulating tumour cells with coherent anti-Stokes Raman scattering microscopy R Mitra, O Chao, Y Urasaki, OB Goodman, TT Le BMC cancer 12, 1-9, 2012 | 89 | 2012 |
Efficacy and safety of telaglenastat plus cabozantinib vs placebo plus cabozantinib in patients with advanced renal cell carcinoma: the CANTATA randomized clinical trial NM Tannir, N Agarwal, C Porta, NJ Lawrence, R Motzer, B McGregor, ... JAMA oncology 8 (10), 1411-1418, 2022 | 87 | 2022 |
Apalutamide plus abiraterone acetate and prednisone versus placebo plus abiraterone and prednisone in metastatic, castration-resistant prostate cancer (ACIS): a randomised … F Saad, E Efstathiou, G Attard, TW Flaig, F Franke, OB Goodman, ... The Lancet Oncology 22 (11), 1541-1559, 2021 | 86 | 2021 |
Role of arrestins in G-protein-coupled receptor endocytosis OB Goodman Jr, JG Krupnick, F Santini, VV Gurevich, RB Penn, ... Advances in pharmacology 42, 429-433, 1997 | 84 | 1997 |
The α Chain of the AP-2 Adaptor Is a Clathrin Binding Subunit (∗) OB Goodman, JH Keen Journal of Biological Chemistry 270 (40), 23768-23773, 1995 | 77 | 1995 |